NCT04872855

Brief Summary

The aim of this study is to assess the long-term performance and safety of HLS KneeTec cementless and hybrid fixation knee prosthesis when used in standard medical practice.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2024

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

4.4 years

First QC Date

April 26, 2021

Last Update Submit

February 4, 2025

Conditions

Keywords

Knee ArthroplastyProsthesisImplantsHLS implantsarthroplasty

Outcome Measures

Primary Outcomes (1)

  • Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery

    Kaplan Meier survival rate up to 10 years after the surgery.

    10-year

Secondary Outcomes (4)

  • Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery

    starting preoperatively up to 10 years

  • Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery

    5 and 10 years

  • Radiographic analysis of the HLS KneeTec cementless and hybrid fixations at 4 months, 1, 5 and 10 years minimum

    4 months, 1, 5 and 10 years

  • Evaluation of safety performance during the surgery up to 10 years after the surgery

    starting intraoperatively up to 10-year FU

Interventions

patient with HLS KneeTec cementless and hybrid fixation prosthesis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be included. All eligible patients seen in consultation and who agree to participate in the study should be included, systematically and consecutively, since the initiation of the study

You may qualify if:

  • Male or female aged 18 - 80 years old at the time of the surgery
  • Implanted (or with an indication) with an HLS KneeTec Cementless or hybrid fixation according to the Instructions for Use (IFU)
  • Patients agree to consent to collect data from their medical records and agree to answer questionnaires for the purposes of the study.

You may not qualify if:

  • \- Patients under guardianship and/or those who, according to the investigator or his delegated research team, will not be able to comply with the study procedures. (e.g. illiteracy, recent psychotic or manic disorders and/or inability to comply with routine follow-up visits.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Chu Angers

Angers, 49933, France

Location

Clinique Du Parc

Caen, 14000, France

Location

Centre Hospitalier Compiegne Noyon

Compiègne, 60200, France

Location

MeSH Terms

Interventions

Arthroplasty, Replacement, Knee

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Franck MABESOONE, MD

    CH COMPIEGNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2021

First Posted

May 5, 2021

Study Start

July 17, 2020

Primary Completion

December 19, 2024

Study Completion

December 19, 2024

Last Updated

February 6, 2025

Record last verified: 2025-02

Locations